Cargando…

2439. Outcomes of Minocycline Use on Gram-Negative Infections and Implications of MIC

BACKGROUND: Minocycline (MINO) is a treatment option for Acinetobacter baumannii and Stenotrophomonas maltophilia infections due to high in vitro susceptibility. Literature suggests it may also be an option for carbapenamase-producing enterobacteriaceae. MINO minimum inhibitory concentrations (MICs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jennifer, Kubin, Christine J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255542/ http://dx.doi.org/10.1093/ofid/ofy210.2092

Ejemplares similares

2132. Multicenter Evaluation of Eravacycline MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Traczewski, Maria M, et al.
Publicado: (2019)

2131. Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2019)

Reproducibility of Ceftolozane/Tazobactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram-negative MIC Panels
por: Harrington, Amanda, et al.
Publicado: (2017)

Reproducibility of Ceftazidime/Avibactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
por: Humphries, Romney, et al.
Publicado: (2017)

230. Multicenter Assessment of the Accuracy of MIC Results for Colistin with MicroScan Dried Gram Negative MIC Panels using CLSI Breakpoints
por: Riedel, Stefan, et al.
Publicado: (2022)

2823. In Vitro Efficacy of Minocycline on Clinical Gram Negative Bacterial Isolates
por: Saleh, Omar M Abu, et al.
Publicado: (2023)

1620. Minocycline Activity Against Unusual Clinically Significant Gram-Negative Pathogens
por: Shorttidge, Dee, et al.
Publicado: (2020)

520. Development of Cefepime-taniborbactam MIC Antimicrobial Susceptibility Test (AST) for Enterobacterales and Pseudomonas aeruginosa on MicroScan Dried Gram-negative MIC Panels
por: Fernandez, Enrique J, et al.
Publicado: (2022)

2439. The role of positive externalities in economic evaluations of new antibiotics: modeling the impact of reduced transmission in healthcare facilities
por: Nelson, Richard, et al.
Publicado: (2019)

342. Multicenter Evaluation of Fosfomycin MIC Results for Enterobacterales Using EUCAST V11 Breakpoints (i.v. and oral for uncomplicated UTI only, E. coli) on MicroScan Dried Gram Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2022)

Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens
por: Shortridge, Dee, et al.
Publicado: (2021)

667. Multicenter Assessment of Enterobacterales, Salmonella spp. and Pseudomonas aeruginosa Using Updated CLSI Levofloxacin Breakpoints on MicroScan Dried Gram Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2020)

2439 Depression, anxiety, and planning for the future: Associations with advance care planning
por: McMahan, Ryan, et al.
Publicado: (2018)

2439. Excess Length of Stay and Mortality among the Critically Ill Adult Patients with Catheter-Associated Urinary Tract Infections in a Tertiary Care Teaching Hospital in Nepal
por: Shrestha, Sailesh K
Publicado: (2023)

673. Updated CLSI Ciprofloxacin Breakpoints from a Multicenter Assessment for Enterobacterales, Salmonella spp. and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
por: Traczewski, Maria M, et al.
Publicado: (2020)

2415. Comparison of Minocycline MIC’s Obtained by Etest to Those Obtained by Broth Microdilution in a Bank of Isolates of Acinetobacter baumannii Collected in Southeastern Michigan
por: Parsons, Leo, et al.
Publicado: (2018)

Performance evaluation of the UMIC(®) Cefiderocol to determine MIC in Gram-negative bacteria
por: Dortet, Laurent, et al.
Publicado: (2023)

LiF Reduces MICs of Antibiotics against Clinical Isolates of Gram-Positive and Gram-Negative Bacteria
por: Syed, H. C., et al.
Publicado: (2012)

392. Epidemiology and Treatment Outcome of Gram-Negative Polymicrobial, Gram-Positive Polymicrobial and Mixed Polymicrobial Prosthetic Joint Infection
por: Hooshmand, Babak, et al.
Publicado: (2019)

2815. Outcomes of Novel Antimicrobials Compared to Polymyxin B for treatment of infections due Carbapenem-Resistant Enterobacterales Infections
por: Zheng, Tina, et al.
Publicado: (2023)

Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of gram-negative rods
por: Bardet, Lucie, et al.
Publicado: (2019)

Appropriateness of Gram-Negative Agent Use at a Tertiary Care Hospital in the Setting of Significant Antimicrobial Resistance
por: Vora, Neil M., et al.
Publicado: (2015)

131. Duration of Therapy for the Treatment of Gram-Negative Bloodstream Infections
por: Shulder, Stephanie, et al.
Publicado: (2019)

200. Comparison of Clinical Outcomes among Patients Treated with Ceftriaxone 2 Grams versus 1 Gram Daily for Gram-Negative Bacteremia
por: Huynh-Phan, Ricky, et al.
Publicado: (2023)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

2060. Comparison of Plazomicin MIC Test Strip and Broth Microdilution MIC Results for 125 Enterobacteriaceae
por: Koeth, Laura, et al.
Publicado: (2018)

254. Genomic diversity of Gram-negative Bacilli from Bloodstream Infections in Hospitalized Children
por: Blumenthal, Jennifer, et al.
Publicado: (2023)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

1253. Optimization of empiric gram-negative infections with the combination antibiogram
por: Leung, Anthony K, et al.
Publicado: (2023)

151. Comparing the Clinical Utility of Rapid Diagnostic Tests for Gram-Negative Bloodstream Infection Using a Desirability of Outcomes Ranking
por: Claeys, Kimberly C, et al.
Publicado: (2019)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

Antimicrobial resistance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amoxicillin
por: Kirchner, Miranda, et al.
Publicado: (2014)

1486. Evaluation of the Impact of Homelessness on Presentation and Outcomes of Gram-Negative Sepsis
por: An Chiu, Chiao, et al.
Publicado: (2019)

141. Use of Rapid Diagnostic Testing in Gram-negative Bloodstream Infections with and without Antimicrobial Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2019)

1283. High Dose Minocycline for the Treatment of Acinetobacter Infections
por: Herbin, Shelbye R, et al.
Publicado: (2021)

1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases
por: Gaspard, Laura, et al.
Publicado: (2018)

The Association of Molecular Characteristics, Vancomycin MIC and Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Osteoarticular Infections in Children
por: McNeil, Jonathon, et al.
Publicado: (2017)

2753. Real-World Use of Cefiderocol Treating Non-COVID Patients with Confirmed Gram-Negative Infections in US Hospitals During January 2020-June 2022
por: Cai, Bin, et al.
Publicado: (2023)

2282. Characterizing Antibacterial Regimen Modification, Patient Characteristics, and Outcomes for Patients with Complicated Gram-Negative Bacterial Infections
por: Yamaki, Jason, et al.
Publicado: (2023)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4irthhu0gmmjpriq2dmaaq4578